NVDA
NVIDIA Corporation
NVDA has the edge over UPBD overall, supported by stronger valuation and stronger modeled upside.
UPBD
Upbound Group, Inc.
UPBD trails on the overall score without a compensating advantage in the available component scores.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
UPBD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
UPBD's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over UPBD in the historical PE scenario, which offers more potential upside but is not a forecast.
UPBD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 5.3x | $23.88 | — |
| Cheap | 11x | $21.16 | -11% |
| Current | 13x | $23.88 | — |
| Fair | 15x | $28.18 | +18% |
| Expensive | 31x | $59.71 | +150% |
Historical ranges are pointers, not guarantees.
UPBD's PE is in its fair range at 13x. If earnings grow as analysts expect, today's price would be 5.3x next year's earnings, in its cheap range.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
UPBD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect UPBD's earnings to grow, with its revenue and profitability holding steady.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over UPBD on earnings, with more consistent year-over-year improvement.
UPBD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.52 | +136% |
| Q3 2026 | $1.91 | +32% |
| Q2 2026 | $1.55 | -13% |
| Q1 2026 | $1.44 | -32% |
| Q4 2025 | $1.25 | -43% |
| Q3 2025 | $1.45 | -2% |
| Q2 2025 | $1.78 | +76% |
| Q1 2025 | $2.13 | +$2.56 |
| Q4 2024 | $2.21 | +$2.30 |
UPBD's earnings per share have fallen from their peak: $1.91 over the past year, against $3.86 in early 2020.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over UPBD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over UPBD on profitability, with a higher operating margin.
UPBD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | -1.6% |
| Q2 2026 | $1.2B | +0.5% |
| Q1 2026 | $1.2B | +3.7% |
| Q4 2025 | $1.2B | +11% |
| Q3 2025 | $1.2B | +9% |
| Q2 2025 | $1.2B | +7.5% |
| Q1 2025 | $1.2B | +7.3% |
| Q4 2024 | $1.1B | +6% |
UPBD's revenue has held roughly level: $1.1B last quarter, down 1.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.2% | +1.7 points |
| Q2 2026 | 4.7% | +0.3 points |
| Q1 2026 | 6.3% | +1 points |
| Q4 2025 | 4.8% | -2.5 points |
| Q3 2025 | 4.5% | -2 points |
| Q2 2025 | 4.4% | -3.1 points |
| Q1 2025 | 5.3% | -0.3 points |
| Q4 2024 | 7.3% | +1.8 points |
UPBD's operating margin was 6.2% last quarter, up 1.7 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over UPBD on cash flow, with more consistent year-over-year improvement.
UPBD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $147M | +50% |
| Q2 2026 | $107.8M | +$118.2M |
| Q1 2026 | $154.7M | +22% |
| Q4 2025 | $24M | +$98.1M |
| Q3 2025 | $97.9M | +11% |
| Q2 2025 | -$10.4M | -1802% |
| Q1 2025 | $127.2M | +278% |
| Q4 2024 | -$74M | -$37.1M |
UPBD generated $434M in free cash flow over the past year, about three times what it generated the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over UPBD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
UPBD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +59K shares |
| 1 year | -0.2% | -123K shares |
| 3 years | +3.4% | +1.9M shares |
| 5 years | -14% | -9.4M shares |
| Available history | +5% | +2.8M shares |
UPBD has 59M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q4 2023 | $26M |
| Q4 2022 | $45.3M |
| Q4 2021 | $370.1M |
| Q3 2021 | $20M |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
UPBD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
UPBD has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
UPBD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.5 | Neutral |
| Stochastic | 86.5 | Overbought |
UPBD's weekly RSI is 66 (neutral) and its Stochastic is 86 (overbought).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
UPBD PE vs Technology Sector
| Metric | UPBD | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 28x | 55% below |
| PE % | 33 | 35 | 2 pts below |
UPBD has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
UPBD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.7 | 28% above |
| 20 week MA | $19.2 | 24% above |
| 50 week MA | $19.1 | 25% above |
| 100 week MA | $21.7 | 10% above |
| 200 week MA | $26.2 | 8.9% below |
UPBD has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
UPBD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.5 | $38.2 | +34% |
| 2021 | $38.2 | $48.1 | +26% |
| 2022 | $48.1 | $22.6 | -53% |
| 2023 | $22.6 | $34.0 | +50% |
| 2024 | $34.0 | $29.2 | -14% |
| 2025 | $29.2 | $17.6 | -40% |
| 2026 YTD | $17.6 | $23.9 | +36% |
UPBD has the edge over NVDA on returns for 2026, with the stronger performance.